LEO GRADY

Leo has 18 years of experience leading development and commercialization of advanced machine learning, AI, computer vision, diagnostic and digital health technologies that have made a significant impact on healthcare practice. During his tenure as CEO of Paige, Leo led the company to become an industry leader, internationally launched several groundbreaking software products and became the first-ever company to receive FDA approval for an AI product in pathology. Leo is currently CEO in Residence with Breyer Capital.